JP2023532681A5 - - Google Patents
Info
- Publication number
- JP2023532681A5 JP2023532681A5 JP2022580239A JP2022580239A JP2023532681A5 JP 2023532681 A5 JP2023532681 A5 JP 2023532681A5 JP 2022580239 A JP2022580239 A JP 2022580239A JP 2022580239 A JP2022580239 A JP 2022580239A JP 2023532681 A5 JP2023532681 A5 JP 2023532681A5
- Authority
- JP
- Japan
- Prior art keywords
- xyl
- rha
- fuc
- saponin
- glc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2025904 | 2020-06-24 | ||
| NL2025904 | 2020-06-24 | ||
| EPPCT/EP2020/071045 | 2020-07-24 | ||
| PCT/EP2020/071045 WO2021014019A1 (en) | 2019-07-25 | 2020-07-24 | Saponin derivatives with improved therapeutic window |
| PCT/EP2021/067227 WO2021260054A2 (en) | 2020-06-24 | 2021-06-23 | Saponin derivatives with improved therapeutic window |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532681A JP2023532681A (ja) | 2023-07-31 |
| JP2023532681A5 true JP2023532681A5 (cg-RX-API-DMAC10.html) | 2024-06-27 |
Family
ID=79282018
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580237A Pending JP2023532680A (ja) | 2020-06-24 | 2021-06-23 | 改善された治療濃度域を有するサポニン誘導体 |
| JP2022580239A Pending JP2023532681A (ja) | 2020-06-24 | 2021-06-23 | 改善された治療濃度域を有するサポニン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580237A Pending JP2023532680A (ja) | 2020-06-24 | 2021-06-23 | 改善された治療濃度域を有するサポニン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20230277612A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4171639A2 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2023532680A (cg-RX-API-DMAC10.html) |
| KR (2) | KR20230043113A (cg-RX-API-DMAC10.html) |
| CN (2) | CN116615249A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2021295292A1 (cg-RX-API-DMAC10.html) |
| CA (2) | CA3184027A1 (cg-RX-API-DMAC10.html) |
| IL (2) | IL299358A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2022016485A (cg-RX-API-DMAC10.html) |
| WO (2) | WO2021260054A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4117730A1 (en) * | 2020-06-24 | 2023-01-18 | Sapreme Technologies B.V. | Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereof |
| WO2024005485A1 (ko) * | 2022-06-26 | 2024-01-04 | 기초과학연구원 | 사포닌 유도체 화합물 및 이를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학적 조성물 |
| KR102887798B1 (ko) * | 2022-06-26 | 2025-11-18 | 기초과학연구원 | 사포닌 유도체 화합물 및 이를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학적 조성물 |
| WO2026087695A1 (en) | 2024-10-24 | 2026-04-30 | Sapreme Technologies B.V. | Treatment for metabolic disorder |
| CN119423084B (zh) * | 2024-11-07 | 2025-10-24 | 四川省烟草公司攀枝花市公司 | 川续断皂苷乙在蚜虫防治中的应用及杀蚜剂 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583112A (en) | 1987-05-29 | 1996-12-10 | Cambridge Biotech Corporation | Saponin-antigen conjugates and the use thereof |
| US5273965A (en) * | 1992-07-02 | 1993-12-28 | Cambridge Biotech Corporation | Methods for enhancing drug delivery with modified saponins |
| US5650398A (en) * | 1992-07-02 | 1997-07-22 | Cambridge Biotech Corporation | Drug delivery enhancement via modified saponins |
| WO1996008274A2 (en) * | 1994-09-13 | 1996-03-21 | Prizm Pharmaceuticals, Inc. | Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| AU710309B2 (en) * | 1995-05-16 | 1999-09-16 | Selective Genetics, Inc. | Compositions containing nucleic acids and ligands for therapeutic treatment |
| US6080725A (en) * | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| NZ500779A (en) * | 1997-05-20 | 2001-06-29 | Galenica Pharmaceuticals Inc | Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| US7727561B2 (en) * | 2001-08-31 | 2010-06-01 | Pacific Arrow Limited | Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| AU2002350181A1 (en) * | 2001-10-31 | 2003-05-12 | Corixa Corporation | Compositions and methods for viral delivery |
| WO2003069997A1 (en) * | 2002-02-04 | 2003-08-28 | Corixa Corporation | Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins |
| CA2522213A1 (en) * | 2003-04-08 | 2004-10-28 | Dante J. Marciani | Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| ES2395818T3 (es) * | 2004-07-13 | 2013-02-15 | Charite - Universitatsmedizin Berlin | Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina |
| WO2009143345A2 (en) * | 2008-05-22 | 2009-11-26 | University Of Massachusetts | Nucleic acid silencing agent-protein conjugates and use thereof for treating hcv-related disorders |
| WO2014163558A1 (en) * | 2013-04-01 | 2014-10-09 | Moreinx Ab | Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds |
| KR102522346B1 (ko) * | 2013-08-29 | 2023-04-17 | 시티 오브 호프 | 세포침투 콘주게이트 및 이의 사용 방법 |
| WO2015184451A1 (en) | 2014-05-30 | 2015-12-03 | Memorial Sloan-Kettering Cancer Center | Minimal saponin analogues, synthesis and use thereof |
| EP3356371A4 (en) * | 2015-09-29 | 2020-06-24 | The University of Chicago | POLYMER CONJUGATE VACCINE |
| WO2017190020A1 (en) * | 2016-04-28 | 2017-11-02 | The Scripps Research Institute | Oligonucleotide conjugates and uses thereof |
| WO2018100558A2 (en) * | 2016-12-01 | 2018-06-07 | Takeda Pharmaceutical Company Limited | Cyclic dinucleotide |
| EP3652190B1 (en) * | 2017-07-11 | 2023-06-14 | Freie Universität Berlin | Novel uses of a saponin and method for its isolation |
| US20220023433A1 (en) * | 2018-12-21 | 2022-01-27 | Sapreme Technologies B.V. | Saponin Conjugates |
| EP4003425A2 (en) * | 2019-07-25 | 2022-06-01 | Sapreme Technologies B.V. | Bioactive saponin linked to a functional moiety |
| BR112022001389A8 (pt) * | 2019-07-25 | 2023-04-25 | Univ Berlin Charite | Derivados de saponina com janela terapêutica melhorada |
-
2021
- 2021-06-23 KR KR1020237002633A patent/KR20230043113A/ko not_active Withdrawn
- 2021-06-23 CN CN202180051953.9A patent/CN116615249A/zh active Pending
- 2021-06-23 CA CA3184027A patent/CA3184027A1/en active Pending
- 2021-06-23 AU AU2021295292A patent/AU2021295292A1/en active Pending
- 2021-06-23 CN CN202180051965.1A patent/CN116390932A/zh active Pending
- 2021-06-23 KR KR1020237002612A patent/KR20230043112A/ko active Pending
- 2021-06-23 JP JP2022580237A patent/JP2023532680A/ja active Pending
- 2021-06-23 JP JP2022580239A patent/JP2023532681A/ja active Pending
- 2021-06-23 CA CA3184041A patent/CA3184041A1/en active Pending
- 2021-06-23 EP EP21732938.2A patent/EP4171639A2/en active Pending
- 2021-06-23 AU AU2021295868A patent/AU2021295868A1/en active Pending
- 2021-06-23 IL IL299358A patent/IL299358A/en unknown
- 2021-06-23 MX MX2022016485A patent/MX2022016485A/es unknown
- 2021-06-23 IL IL299359A patent/IL299359A/en unknown
- 2021-06-23 WO PCT/EP2021/067227 patent/WO2021260054A2/en not_active Ceased
- 2021-06-23 US US18/012,694 patent/US20230277612A1/en active Pending
- 2021-06-23 WO PCT/EP2021/067239 patent/WO2021260061A2/en not_active Ceased
- 2021-06-23 EP EP21736583.2A patent/EP4171644A2/en active Pending
- 2021-06-23 US US18/012,698 patent/US20230365617A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022542075A5 (cg-RX-API-DMAC10.html) | ||
| Chen et al. | Voglibose (Basen®, AO-128), one of the most important α-glucosidase inhibitors | |
| US5017566A (en) | Redox systems for brain-targeted drug delivery | |
| US11021506B2 (en) | Thiosaccharide mucolytic agents | |
| WO2011075953A1 (zh) | 多臂聚乙二醇衍生物及其与药物的结合物和凝胶 | |
| TWI326687B (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
| CA2556169A1 (en) | Use of amino-oxy functional groups in the preparation of vaccines | |
| WO2010060260A1 (zh) | 新型的多臂聚乙二醇及其制备方法和应用 | |
| HUP0302269A2 (hu) | Hipokoleszterinémiás szerekként alkalmazható cukor-szubsztituált 2-azetidinonok | |
| JP2000516224A (ja) | 修飾オリゴサッカライド | |
| US7812006B2 (en) | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | |
| CN108350014A (zh) | 氨基糖苷衍生物及其在治疗遗传性病症中的应用 | |
| JP2018528211A5 (cg-RX-API-DMAC10.html) | ||
| MX2022016485A (es) | Derivados de saponina con ventana terapeutica mejorada. | |
| CA2272701C (en) | Glycolipid mimics and methods of use thereof | |
| JPH11508564A (ja) | 合成n−結合グリココンジュゲートを製造するための方法 | |
| US7582737B2 (en) | Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides | |
| US20240299554A1 (en) | Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl units | |
| JP2005041817A (ja) | クルクミノイド配糖体、及びその製造方法 | |
| JP2001500901A (ja) | 抗腫瘍および駆虫剤を溶解するために特に利用されるチオウレイド―シクロデキストリン、およびその製造方法 | |
| US20070021380A1 (en) | Novel drug delivery compositions | |
| CN111593080B (zh) | 一种α-半乳糖抗原活性前体及其合成方法和应用 | |
| JP2023533693A5 (cg-RX-API-DMAC10.html) | ||
| JP2023542500A5 (cg-RX-API-DMAC10.html) | ||
| JP2000191685A (ja) | コレスタノール化合物及びこれを含有する医薬 |